글 수정하기
글쓴이
E-mail
Homepage
글제목
글
I'm on business <a href=" http://www.judoyuko.com/s-gra-price.pdf#unless ">s gra 100 pills</a> The Food and Drug Administration is investigating a reported case of the brain infection progressive multifocal leukoencephalopathy in a patient taking the Novartis MS drug Gilenya in Europe. The regulator announced the investigation Thursday and said in a statement that this is the first case of PML reported in a Gilenya patient who has not taken Biogen Idec's Tysabri, which the regulator notes has been associated with a higher risk of PML.
비밀번호
(수정과 삭제시 필요!! )